115 related articles for article (PubMed ID: 6735434)
41. Ovarian cancer-associated antibodies recovered from ascites: their use for the isolation of ovarian cancer-associated antigen to produce monoclonal antibodies.
Giancotti FR; Dorsett BH; Qian HN; Cronin WJ; Barber HR; Ioachim HL
Gynecol Oncol; 1990 Apr; 37(1):24-8. PubMed ID: 2182406
[TBL] [Abstract][Full Text] [Related]
42. Demonstration of tumor-associated transplantation antigens in rat mammary tumors induced by 7,12-dimethylbenz (alpha) anthracene.
Silinskas KC; Fang W; Mukkur TK
Oncology; 1974; 29(4):273-82. PubMed ID: 4842402
[No Abstract] [Full Text] [Related]
43. Immunologic responses to a murine mammary adenocarcinoma. II. Monocyte effector activation by humoral factors.
Yamamura Y
Int J Cancer; 1977 May; 19(5):717-24. PubMed ID: 863548
[TBL] [Abstract][Full Text] [Related]
44. Rodent model of systemic mammary tumor disease by surgical removal of the spontaneously metastasizing SMT2A mammary carcinoma: inhibitory effect of the stable prostacyclin analogue cicaprost on occult metastasis.
Schirner M; Schneider MR
Int J Cancer; 1995 Jul; 62(2):205-9. PubMed ID: 7622297
[TBL] [Abstract][Full Text] [Related]
45. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
[No Abstract] [Full Text] [Related]
46. Adenosine-3',5'-cyclic monophosphate levels and adenosine-3',5'-cyclic monophosphate phosphodiesterase activity in metastasizing and nonmetastasizing rat mammary carcinomas.
Chatterjee SK; Kim U
J Natl Cancer Inst; 1975 Jan; 54(1):181-6. PubMed ID: 163315
[TBL] [Abstract][Full Text] [Related]
47. Antigen specificity and immunogenic capacity of 3m KCl cell extracts from ascites tumour ATPCplus.
Marconi P; Bistoni F; Pitzurra M
Boll Ist Sieroter Milan; 1974; 53(2):377-91. PubMed ID: 4214542
[No Abstract] [Full Text] [Related]
48. Monoclonal antibodies against antigens displayed on a progressively growing mammary tumor.
Tax A; Manson LA
Proc Natl Acad Sci U S A; 1981 Jan; 78(1):529-33. PubMed ID: 6264447
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical expression of monoclonal antibodies (epi-1 and myo-1) derived from human breast cancer against rat mammary tumors.
Yamamoto H; Imai S; Yamamoto I
Exp Toxicol Pathol; 1992 Sep; 44(5):235-8. PubMed ID: 1446159
[TBL] [Abstract][Full Text] [Related]
50. [Solubilization of antigens from ATPC+ ascitic tumor using hypertonic sodium solution].
Marconi P; Bistoni F; Pitzurra M
Boll Soc Ital Biol Sper; 1973 May; 49(10):534-8. PubMed ID: 4132962
[No Abstract] [Full Text] [Related]
51. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
[TBL] [Abstract][Full Text] [Related]
52. Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity.
Archer TP; Bretscher P; Ziola B
Clin Exp Metastasis; 1990; 8(6):519-32. PubMed ID: 2225567
[TBL] [Abstract][Full Text] [Related]
53. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice.
DeLustro F; Haskill JS
J Natl Cancer Inst; 1980 Jan; 64(1):125-30. PubMed ID: 6928037
[TBL] [Abstract][Full Text] [Related]
54. Role of humoral immunity in progressive and regressive and metastatic growth of the canine transmissible venereal sarcoma.
Fenton MA; Yang TJ
Oncology; 1988; 45(3):210-3. PubMed ID: 3368197
[TBL] [Abstract][Full Text] [Related]
55. A quantitative assay for tumor antigen based on inhibition of cytotoxicity of sensitized lymphocytes.
Huber S; Lucas ZJ
Int J Cancer; 1979 Feb; 23(2):224-32. PubMed ID: 83968
[TBL] [Abstract][Full Text] [Related]
56. Immunologic responses to a murine mammary adenocarcinoma. I. Passive transfer of immunity by sera from tumor-bearing mice.
Yamamura Y; Virella G; Haskill JS
Int J Cancer; 1977 May; 19(5):707-16. PubMed ID: 68018
[TBL] [Abstract][Full Text] [Related]
57. Monoclonal antibodies against a 65-kDa tumor-associated phosphoprotein: development and use in cancer detection.
Wang S; Mirowski M; Sherman U; Walaszek Z; Hanausek M
Hybridoma; 1993 Apr; 12(2):167-76. PubMed ID: 8314597
[TBL] [Abstract][Full Text] [Related]
58. The effects of immune depression on chemical carcinogenesis in the rat. I. Regional lymphadenectomy.
Bolton PM
Oncology; 1973; 27(5):430-6. PubMed ID: 4719017
[No Abstract] [Full Text] [Related]
59. [Location of viral antigens in mouse mammary adenocarcinoma by immunoperoxidase].
Thomas JA; Garzon S; Lambré C
C R Acad Hebd Seances Acad Sci D; 1973 Jul; 277(4):457-62. PubMed ID: 4362169
[No Abstract] [Full Text] [Related]
60. Immunoelectrophoretic analysis of DMBA-induced rat mammary tumours.
Kellen JA; Lo AC; Kolos TO
Oncology; 1971; 25(5):401-9. PubMed ID: 4111371
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
